JEAN DORTILUS: Open Payments
NPI 1063658524 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 37 payments from 7 companies in 2025. Trend: 2023 $1,331 · 2024 $657 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $280 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $148 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Auvelity, CAPLYTA, REXULTI, TRINTELLIX, Sunosi, Quviviq, Jornay PM, COBENFY.
Industry payments across TX — which companies pay providers there.
